- You are viewing a Navigating Care library resource.
- Go to Library
Treatment of Untreated Adult Acute Lymphoblastic Leukemia
For information about the treatments listed below, see the Treatment Option Overview section.
Standard treatment of adult acute lymphoblastic leukemia (ALL) during the remission induction phase includes the following:
- Combination chemotherapy.
- Tyrosine kinase inhibitor therapy with imatinib mesylate, in certain patients. Some of these patients will also have combination chemotherapy.
- Supportive care including antibiotics and red blood cell and platelet transfusions.
- Central nervous system (CNS) prophylaxis therapy including chemotherapy (intrathecal and/or systemic) with or without radiation therapy to the brain.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Learn more:
- General Information About Adult Acute Lymphoblastic Leukemia
- Stages of Adult Acute Lymphoblastic Leukemia
- Treatment Option Overview
- Treatment of Untreated Adult Acute Lymphoblastic Leukemia
- Treatment of Adult Acute Lymphoblastic Leukemia in Remission
- Treatment of Recurrent Adult Acute Lymphoblastic Leukemia
- To Learn More About Adult Acute Lymphoblastic Leukemia
Related Articles
- General Information About Adult Acute Lymphoblastic Leukemia
- Stages of Adult Acute Lymphoblastic Leukemia
- Treatment Option Overview
- Treatment of Untreated Adult Acute Lymphoblastic Leukemia
- Treatment of Adult Acute Lymphoblastic Leukemia in Remission
- Treatment of Recurrent Adult Acute Lymphoblastic Leukemia
- To Learn More About Adult Acute Lymphoblastic Leukemia